OBJECTIVE
To determine the effect of combinations of statins, aspirin, beta blockers, and angiotensin converting enzyme inhibitors in the secondary prevention of all cause mortality in patients with ischaemic heart disease.
DESIGN
Open prospective cohort study with nested case-control analysis.
SETTING
1.18 million patients registered with 89 general practices across 23 strategic health aut...